VECTICANN Trademark

Trademark Overview


On Monday, January 6, 2025, a trademark application was filed for VECTICANN with the United States Patent and Trademark Office. The USPTO has given the VECTICANN trademark a serial number of 79418894. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, February 11, 2026. This trademark is owned by 113 BOTANICALS LIMITED. The VECTICANN trademark is filed in the Pharmaceutical Products category with the following description:

Medicinal preparations for treatment of intractable nausea and vomiting associated with chemotherapy, fibromyalgia, chronic pain disorders, spasticity, Parkinson's disease, multiple sclerosis, insomnia, anxiety, PTSD, severe treatment-resistant epilepsy, Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis complex, Crohn's disease and ulcerative colitis; transdermal patches for use in the treatment of intractable nausea and vomiting associated with chemotherapy, fibromyalgia, chronic pain disorders, spasticity, Parkinson's disease, multiple sclerosis, insomnia, anxiety, PTSD, severe treatment-resistant epilepsy, Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis complex, Crohn's disease and ulcerative colitis; adhesive skin patches for medical purposes, namely, treatment of intractable nausea and vomiting associated with chemotherapy, fibromyalgia, chronic pain disorders, spasticity, Parkinson's disease, multiple sclerosis, insomnia, anxiety, PTSD, severe treatment-re...
vecticann

General Information


Serial Number79418894
Word MarkVECTICANN
Filing DateMonday, January 6, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateWednesday, February 11, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 3, 2026

Trademark Statements


Goods and ServicesMedicinal preparations for treatment of intractable nausea and vomiting associated with chemotherapy, fibromyalgia, chronic pain disorders, spasticity, Parkinson's disease, multiple sclerosis, insomnia, anxiety, PTSD, severe treatment-resistant epilepsy, Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis complex, Crohn's disease and ulcerative colitis; transdermal patches for use in the treatment of intractable nausea and vomiting associated with chemotherapy, fibromyalgia, chronic pain disorders, spasticity, Parkinson's disease, multiple sclerosis, insomnia, anxiety, PTSD, severe treatment-resistant epilepsy, Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis complex, Crohn's disease and ulcerative colitis; adhesive skin patches for medical purposes, namely, treatment of intractable nausea and vomiting associated with chemotherapy, fibromyalgia, chronic pain disorders, spasticity, Parkinson's disease, multiple sclerosis, insomnia, anxiety, PTSD, severe treatment-resistant epilepsy, Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis complex, Crohn's disease and ulcerative colitis; medicated skin preparations, namely skin patches, for treatment of intractable nausea and vomiting associated with chemotherapy, fibromyalgia, chronic pain disorders, spasticity, Parkinson's disease, multiple sclerosis, insomnia, anxiety, PTSD, severe treatment-resistant epilepsy, Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis complex, Crohn's disease and ulcerative colitis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 13, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party Name113 BOTANICALS LIMITED
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Thursday, March 13, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Sunday, March 16, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, March 16, 2025APPLICATION FILING RECEIPT MAILED
Monday, June 16, 2025ASSIGNED TO EXAMINER
Monday, June 16, 2025NON-FINAL ACTION WRITTEN
Tuesday, June 17, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, August 6, 2025REFUSAL PROCESSED BY MPU
Wednesday, August 6, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, August 23, 2025REFUSAL PROCESSED BY IB
Thursday, February 5, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 5, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 5, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 6, 2026APPROVED FOR PUB - PRINCIPAL REGISTER